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ABSTRACT 
Escherichia coli Strain Diversity in Humans: 
Effects of Sampling Effort and Methodology 
Emily R. Neal 
Studies investigating Escherichia coli strain diversity and demographics in human 
hosts are frequently inconsistent regarding sampling effort and methodology while 
current strain typing methods are often expensive or laborious. To rectify these 
inconsistencies, sampling effort was investigated by comparing the diversity of 15-isolate 
collections to 100-isolate collections from 3 human subjects. Temporal variation in E. 
coli strain diversity was also studied by collecting 15 isolates once every 6 months. 
Additionally, strain identification and diversity collected by different sampling methods 
(fecal swabs vs. anal swabs collected at different times around defecation) were 
compared to identify any inherent biases in sampling method. This study employed 
pyroprinting, a new inexpensive and simple strain typing method using pyrosequencing, 
to generate DNA fingerprints (or pyroprints) based on the Intergenic Transcribed Spacer 
sequences in the ribosomal RNA operon to differentiate E. coli strains. Differences in 
strain diversity were apparent when comparing sampling efforts. The sampling effort 
investigation suggested that certain subjects hosted very large and highly diverse E. coli 
strain populations such that even 100 isolates may not fully represent E. coli strain 
populations in human hosts. Instead, the sampling effort required to accurately represent 
strain demographics may depend on strain richness and evenness within each host. The 
temporal investigation yielded similar or greater strain abundance and diversity compared 
to other typing methods in the literature suggesting pyroprinting is a similarly 
discriminating tool. When agglomerated over time or by subject, no significant 
differences in diversity were observed between subjects or between sampling methods 
despite visible differences in strain richness and evenness. 
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CHAPTER 1 
Introduction 
Escherichia coli (E. coli) are generally commensal inhabitants of the mammalian 
and avian gastrointestinal tract (1, 2). Because they are shed in the host feces, E. coli are 
commonly used as fecal indicator bacteria (FIB) when found in environments such as 
soil, resource water, or recreational water (3–5). Government agencies like the USFDA, 
USEPA and state water quality control boards use E. coli counts to regulate food and 
water resources (5–7) because their presence indicates fecal contamination that can carry 
enteric pathogens (3, 4, 8). While pathogenic and antibiotic-resistant strains of E. coli are 
heavily investigated (9–11), relatively little is known about the ecology and strain 
dynamics of commensal E. coli within humans and other hosts of interest. 
Because of its status as a FIB, researchers often use the E. coli species as a tool 
for tracking the source of fecal contamination (5, 12, 13). Microbial source tracking 
(MST) is a relatively recent and rapidly growing effort to find the sources of microbes 
associated with fecal contamination. The general approach for MST identifies a particular 
fecal-associated microbial species (or group of species) from the environment and 
matches them to a host species (e.g. cow, human, swine, etc.) or location, based often on 
host specific probes or a library-dependent set of diagnostic patterns from potential 
sources (5, 13). Using E. coli for MST is only effectual because of its typically 
commensal relationship with many host species. Characterizing the diversity and ecology 
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of commensal E. coli is important for the use of E. coli as a suitable MST species and for 
establishing the parameters (e.g. sample sizes necessary) for library-dependent MST 
methods. 
Variations in microbial diversity and ecology in humans are often associated with 
changes in health. Several studies establish a relationship between the E. coli phylotypes 
and strains present and incidence of both Crohn’s disease and inflammatory bowel 
disease (IBD) (14–17). Scanlan et al. (18) found significantly lower temporal stability for 
major fecal bacteria in Crohn’s disease patients compared to healthy patients, suggesting 
that the temporal stability of other commensals (e.g. E. coli) may also be related to 
disease onset or progression. Therefore, commensal E. coli strain presence, abundance, 
and diversity may establish a healthy norm for medical comparisons, acting as a potential 
indicator for general stability of the intestinal microflora. 
The strain diversity of E. coli in humans is commonly evaluated using a few 
isolates from many human subjects to provide a snapshot of diversity within a population 
(12, 19). Very few studies describe strain diversity and stability in individual hosts (12). 
Additionally, many studies only identify E. coli phylotypes (A, B1, B2, & D) (9, 19–24), 
which are broad phylogenetic groups encompassing many different strains. Therefore, 
more sensitive strain typing methods are required to track specific E. coli strains within a 
host population. 
E. coli strains are commonly differentiated using both phenotypic and genotypic 
strain typing methods (5, 13). Unfortunately, the strain typing method used appears to 
influence the observed strain demographics and diversity in humans (25, 26) and the 
sampling effort required to accurately represent a population. In addition, studies 
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investigating temporal strain dynamics in individual hosts were inconsistent regarding 
collection methods, number of isolates collected, and strain typing method used (10, 25, 
27, 28, 29, 30). 
Early studies by Sears et al. (27, 28) indicate one or two strains persisting over at 
least a year while several less abundant strains were also detected. In these studies, 
isolates from several human subjects were obtained from feces over several years and 
strains were determined by antigen typing. The number of isolates collected varied with 
each sampling event. 
Caugant et al. (29) also found stably maintained E. coli strains in human hosts. In 
this study, 550 E. coli isolates were collected from a single human subject and were 
grouped into 53 strains using electrophoretic typing of 15 enzymes. Over the course of 11 
months, one E. coli strain persisted for 7 months and one strain persisted for 5 months. 
The number of isolates collected during each sampling event ranged from 11 to 74. While 
differences between sampling techniques were investigated, the different sample types 
were not taken on the same day, leaving time as a variable for change. 
Anderson et al. (25) evaluated several human subjects over a seven month period 
and observed a higher degree of diversity than Sears et al. This group used two different 
typing methods to evaluate isolates taken from a single fecal sample from each subject 
from each subject per month. Antibiotic resistance analysis (ARA) was used to type 25 
isolates while ribotyping was used to type 5 isolates. Ribotyping yielded less diversity 
than antibiotic resistance typing, though this could be an artifact of sampling effort. A 
maximum of 31 unique antibiotic resistance profiles and 11 unique ribotypes were 
observed in a single human host over the sampling period. Most strains detected by either 
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method did not persist for more than one month. However, one strain did persist for more 
than five months. Though diversity comparisons between subjects were not directly 
measured, the persistence results also seemed to indicate variable degrees of strain 
richness and diversity across human subjects. 
Lastly, Johnson et al. (10) investigated E. coli persistence and sharing between six 
household members (including one dog) using rapid amplified polymorphic DNA 
(RAPD) analysis and pulse field gel electrophoresis (PFGE) to identify strains. Five 
isolates were collected from six fecal samples from each subject over a three year period. 
Only a total of 14 E. coli strains were identified in the entire three-year study from which 
extensive strain sharing was observed between all household members. Certain strains 
persisted in human subjects up to almost three years. In a similar study, Damborg et al. 
(30) investigated E. coli strain diversity in 18 human subjects over six months and 
reported strains shared within a household commonly persist in individuals for over six 
months. E. coli isolates were collected using either rectal or fecal swabs from subjects 
grouped in 8 households. Only a maximum of ten isolates collected over the entire six 
months from each subject were analyzed using amplified fragment length polymorphism 
(AFLP). In general, the investigation found high diversity over the six months detecting 
an average of six strains per ten E. coli isolates. The data presented did not report any 
impact of the different sampling methods used. Because subjects in both the Johnson and 
Damborg studies were members of the same households, strains could have been re-
acquired between housemates rather than persisting in an individual. 
Overall, the existing temporal studies in the literature review were inconsistent in 
the number of isolates collected per sampling event. Inconsistencies not only prevent 
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direct diversity comparisons between sampling events but may also lead to some 
samplings in which only dominant strains are detected and other samplings in which 
minor strains can also be detected. Additionally, many of these studies lacked evidence 
supporting the level of sampling effort used to investigate strain dynamics. The number 
of isolates necessary for representative sampling has not been investigated for any strain 
typing method to date. Studies in the literature collected isolates from either feces or 
anal-rectal swabs, but analysis of differences between sampling strategies was limited to 
the detection of a particular strain or strain characteristic, usually related to pathogenicity 
(31–34). 
To rectify this lack of information regarding the diversity of commensal E. coli 
and clarify inconsistencies in the literature, we investigated E. coli strains using a new 
genotypic strain typing method called pyroprinting described by Black et al. (unpublished 
35, 36). Fifteen isolates were collected from fecal samples once a month for six months. 
Sampling effort was also investigated by comparing collections of 100 E. coli isolates to 
collections of 15 isolates taken at the same time. In addition, this study is the first to 
analyze the effects of sampling method on observed commensal E. coli strain diversity 
and detection in humans. 
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CHAPTER 2 
Methods and Materials 
 
Study Design and Sampling 
Samples were collected from three human subjects once a month for a total of six 
months. Subject B (male) was age 21-22 over the course of the study; subjects A and C 
(females) were ages 25 and 20-21, respectively. During one sampling event, different 
methods were used to collect E. coli: 1) an anal swab directly before defecation, 2) an 
anal swab immediately after defecation prior to wiping, 3) an anal swab several hours 
later post-defecation, and 4) a swab from the homogenized fecal sample collected for 
that day (Fig. 1).  
Swabs were immediately streaked on MacConkey agar and taken to the lab for 
processing within 24 hours. Streaked plates were stored at 4°C if necessary prior to an 
overnight incubation at 37°C. Fifteen isolates from each original MacConkey plate were 
selected for further investigation. To address questions regarding sampling effort, 100 E. 
coli isolates were collected from homogenized fecal samples on month 1 and month 6 for 
each subject. Approximately three to five grams were diluted in sterile water to a 
concentration of 100 mg feces•ml
-1
. Dilutions of 10
-2
, 10
-3
, and 10
-4
 mg•ml
-1
 were plated 
on MacConkey agar, and isolates were selected for confirmation. 
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Figure 1.  Sampling Plan for Subject A. Letters represent sampling method where D = diluted stool 
samples, F = fecal swab, B = before swab, I = immediate swab, and L = later swab. The sampling strategy 
described in month 2 for subject A was exactly the same for subjects B and C except the month selected for 
different sampling methods.  Month 1 was selected for subject B, and month 4 was selected for subject C. 
 
 
 
E. coli Confirmation.  
MacConkey agar was used as the initial isolation step. To ensure pure cultures, 
pink colonies selected from the first MacConkey plate were streaked onto MacConkey a 
second time. From this second plate, pink colonies were streaked onto Luria-Bertani (LB) 
agar. Isolates on LB were confirmed as E. coli if they:  1) produced a green metallic 
sheen on eosin-methylene blue agar, 2) produced indole in tryptone broth, and 3) 
remained negative for growth on Simmons’ citrate agar. 
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Pyroprinting 
The method described by Black et al. (unpublished 35) was used for this study. 
Specifically, two separate colony PCR reactions amplified each of two genomic 
intergenic transcribed spacer regions (ITS1 and ITS2) using flanking primers described in 
Black et al (unpublished). Gel electrophoresis (2.5% agarose in Tris-acetic acid-EDTA 
buffer) confirmed PCR success. PCR products were processed for pyrosequencing with a 
Qiagen Pyromark
®
 Q24 using dispensation sequences established in Black et al 
(unpublished 35). A pyroprint is defined as the ordered list of light-emission peak heights 
for each nucleotide dispensation in a sequencing reaction. Pyroprint data were exported 
from the Pyromark
®
 software and collected for pairwise similarity analysis. 
 
Statistics 
Pyroprints for the same ITS regions were compared between different E. coli 
isolates using Pearson’s correlation to assess similarity. For clarification, at the end of 
this analysis two correlation matrices were produced:  one comparing pyroprints from 
ITS1 for all isolates and another comparing pyroprints from ITS2 for the same isolates. A 
novel algorithm was developed for clustering isolates into strains using correlation values 
between isolates from both ITS regions (35–37). For this study, the algorithm was 
customized such that subject and sampling time were considered when clustering (37). 
Isolates collected within a subject were clustered first at month 1, then month 2, and so 
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on. This process was completed for all three subjects, and only then were clusters 
compared across subjects. 
The Shannon-Weaver index and Pielou’s evenness were calculated for every 
sample type collected during each sampling event from each subject. Diversity indices 
were used to compare temporal diversity and strain diversity identified by the different 
sampling methods. One-way repeated measures analysis of variance was performed using 
Minitab® 16 to compare Shannon-Weaver values and evenness between subjects across 
all six months and between sampling methods (B, F, I, L) across all subjects. 
The Freeman-Halton version of Fisher’s exact test was used to compare the 
distribution of strains identified from the dilution samples and fecal swab samples 
collected together at the same times. This test was conducted six times using the FREQ 
procedure in SAS 9.2: one for each sampling event (month 1 and month 6) from all 
subjects (A, B, and C). 
To compare the dilution sampling effort to the fecal swab sampling, rarefaction 
curves were generated for the same six data sets (described above), EstimateS (38) was 
used to calculate the number of strains observed (Sobs) with the Mao Tau analytical 
method. Data were exported and graphed using Microsoft® Excel 2010. 
To assess similarity of sampling methods the frequency of detection across all 
sampling methods in a given strain was compared using binary logistic regression. Data 
from each subject were analyzed separately in Minitab® 16, and binary logistic 
regression was applied for each strain. 
 
 
10 
 
 
CHAPTER 3 
Results 
 
Effects of Sampling Effort 
Strain distributions from dilutions (100 isolates) and fecal swabs (15 isolates) 
were compared for month 1 and month 6 in all 3 subjects (Fig. 2).  Differences in strain 
distribution across sampling efforts (100 vs. 15 isolates collected) were assessed using 
Fisher’s exact tests.  No significant differences in strain distribution were found between 
the samples collected from subject A (both month 1 and month 6) and between the 
samples from subject B at month 6 (P values > 0.05). All other comparisons showed a 
significant difference in the distribution of strains between the two levels of sampling 
effort. 
Rarefaction curve trajectories measuring number of strains sampled using fecal 
swabs more closely followed curve trajectories generated from the dilution samples (Fig. 
3C, E, F) when the distributions of strains between the two were found to be significantly 
different.  Alternatively, when the distribution of strains was not found to be significantly 
different, the fecal swab rarefaction curves displayed greater curvature than the dilution 
sample rarefaction curves (Fig. 3A, B, D). In these cases, the fecal swabs detected fewer 
strains than dilutions for the same number of collected isolates. For example, the fecal 
swab from subject B month 6 was predicted to detect a total of 6 strains using 13 isolates 
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whereas the dilution would detect 10 strains using 13 isolates (Fig. 3D). Although 
dilution rarefaction curves generated from subject A month 6 (Fig. 3B), subject B month 
1 (Fig. 3C), and subject C month 1 (Fig. 3E) displayed less curvature than the other 
dilution rarefaction curves, none of the curves for either sampling type reached an 
asymptote for number of identified strains indicating that neither 15 nor 100 isolates were 
sufficient to detect the majority of strains present in the fecal samples. 
 
Figure 2. Sampling Effort Distribution Comparisons. Percentage of total isolates collected from a 
particular sampling method (stool dilution or fecal swab) represented by each strain detected for all three 
human subjects A, B, & C from month 1 (M1) or month 6 (M6). Strains detected at less than 10% of the 
total isolates collected from the dilution were categorized together in each figure unless the strain was 
detected again from the fecal swabs (e.g. strain 32 from subject B M1). * indicates significant differences 
(P < 0.05). 
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Figure 3. Sampling Effort Rarefaction Curves.  Rarefaction curves were generated using the Sobs calculated 
with the Mao Tao method for each sampling effort event conducted. All subjects were sampled at month 1 
and month 6. Different numbers of E. coli were isolated using the two methods: Dilution (100 isolates) and 
Fecal (15 isolates). 
 
In general, a majority of isolates collected from fecal swabs (15 isolates total) 
represented strains that were also isolated from fecal dilutions (100 isolates). In the best 
case, 100% of the isolates from subject A at month 1 were represented in the 
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corresponding dilution sample, while in the worst case only 38% of the isolates from 
subject C at month 6 were represented in the dilution sample (Table 1). Perhaps 
unsurprisingly, these two extremes in representation across sampling effort correlate to 
extremes in strain diversity (Fig. 2). 
Table 1. Sampling Effort Strain Representation   
Number of strains detected from both fecal swabs and dilution samples from Months 1 and 6 and percent of 
strains from fecal swabs represented in the dilution sample. 
 Month 1 Month 6 
Subject 
No. of F 
strains 
No. of D 
strains 
No. of F 
strains in D 
(%) 
No. of F 
strains 
No. of D 
strains 
No. of F 
strains in D 
(%) 
A 3 20 3  (100.0) 3 18 2   (66.7) 
B 5 16 4    (80.0) 6 24 4   (66.7) 
C 5 15 3    (60.0) 8 32 3   (37.5) 
Letters represent subject (A-C) or sample type (F and D) as described in Methods and Materials. 
Table displays both the number of strains and percentages of strains detected using fecal swabs that were 
also detected in dilution samples. 
 
Effects of Sampling Method 
Average Shannon-Weaver values for each sampling method were calculated using 
data from all three subjects and compared using repeated measures ANOVA. No 
significant differences were observed between sampling methods (Fig. 4A). The test was 
repeated using Pielou’s evenness values, and again no significant differences were 
observed between mean evenness values of each sampling method (Fig. 4B). However, 
large variability around the means was observed except in the evenness of strains from 
swabs taken before defecation. 
Data from different swab samples collected during a single sample month (Fig. 1) 
were analyzed using binary logistic regression to test the hypothesis that sampling 
method does not affect strain detection. If this were true then each strain would have an 
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equal chance of detection by each sampling method, that is, a particular strain should not 
be represented by isolates from predominantly one sampling method. Binary logistic 
regression requires at least three isolates in each strain to determine significant 
differences (P < 0.05); therefore not all strains detected by the sampling methods could 
be analyzed. 
A) Shannon-Weaver        B) Pielou’s Evenness 
      
Figure 4. Sampling Method Shannon-Weaver and Pielou’s Evenness.  A) Shannon-Weaver values from 
each subject and the average values calculated using all three subjects for every sampling method. No 
significant differences were found between the averages (P >0.05). B) Pielou’s evenness values calculated 
for every sampling method from each subject and the average values calculated using all three subjects. No 
significant differences were found between the sample types (P >0.05) 
 
Between two and six strains from each subject were detected in significantly 
higher proportions by one or two sampling methods, but the proportions of strains with 
three or more isolates varied by subject (Fig. 5). Seven of the 16 strains collected from 
subject A were represented by 3 or more isolates while only 2 of these (29%) were 
detected in significantly different proportions by sampling method. In subject B, 9 out of 
22 strains were represented by more than 3 isolates, and 4 of these (44%) were detected 
in significantly different proportions. Subject C held the extreme with 6 out of 24 strains  
0
0.5
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1.5
2
2.5
0
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1
1.5
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2.5
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15 
 
Figure 5. Strains Identified by Sampling Method.  Strains identified using the four different sampling 
methods and analyzed using binary logistic regression. * identifies strains with a p-value less than α = 0.05, 
indicating sampling methods used to detect a particular strain were disproportionately represented. 
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represented by more than 3 isolates, and all 6 (100%) were detected in significantly 
different proportions by sampling method. 
 
Temporal strain diversity and stability 
Isolates collected from fecal swabs over six months were used for temporal 
comparisons (Fig. 6 & 7). Subject A had the fewest total strains isolated over the study. 
Subjects B and C had more similar numbers of strains detected, although the largest 
number of strains were isolated from C (Table 2).  
 
Figure 6.  Numbers of Strain Detected Monthly.  Number of strains detected from each subject in each of 
six months using F swab samples. 
 
To compare temporal diversity between subjects, Shannon-Weaver index and 
Pielou’s evenness values were calculated for each sampling event and then averaged for 
each subject (excluding month 4 for subject A). Although no significant differences were 
observed between subjects (P > 0.05), both diversity indices were lowest from subject A 
suggesting less strain diversity, while subjects B and C both had higher and more similar 
values of diversity (Table 2). 
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Table 2. Temporal Strain Diversity for Each Subject 
Average strain detection and diversity measurements over the six month study period 
Subject 
(total strains detected) 
Average number of strains 
detected per month (Min-Max) 
Shannon index Pielou’s evenness 
A (15) 3.17*    (≤1-6) 0.93 (± 0.44) a 0.69 (± 0.17) a 
B (25) 6            (4-8) 1.56 (± 0.32) a 0.88 (± 0.08) a 
C (29) 6.67       (5-9) 1.59 (± 0.42) a 0.84 (± 0.12) a 
*Average for subject A calculated using all 6 months, including month 4 in which zero E. coli were 
detected. As this is a descriptive study and the subject did not host E. coli at detectable levels, the study 
aims to present realistic observations which could be applicable to other normal human 
individuals/populations. The average number of strain collected during months only in which E. coli were 
collected was 3.8. 
 
Within all three subjects, the majority of strains were detected only once during 
the six-month study period (Fig. 7 & 8). No strains were detected in more than two 
sampling events from subject A, indicating low strain stability. Low strain stability was 
also observed in subject C, who had the highest percentage of strains detected in only one 
sample (Fig. 8). Interestingly, subject C also had the highest percentage of strains 
detected in four out of six samples, which indicates high strain stability. Strains detected 
multiple times, however, were not necessarily detected in consecutive months. For 
example, strain 33 was detected in months 1, 2, 4, and 5 from subject B but did not 
appear in month 3 (Fig. 7B).  In month 4, no E. coli were detected from subject A (Fig. 
6). Colonies appearing on MacConkey agar from that month were identified as 
Salmonella sp. after analysis using API-20E
®
 strips (data not shown). 
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Figure 7. Temporal Strain Persistence. Persistence of each strain detected using F sampling from each 
subject during the six month study. 
 
 
No formal log was kept regarding subjects’ diets and daily health, but major 
events were recorded. Most notably, subject A traveled between the month 2 and month 3 
collections and experienced a day of diarrhea approximately two weeks before the month 
19 
4 collection. These events coincide with changes in the E. coli strains detected and a lack 
of strain persistence in subject A. Two strains were detected from both month 1 and 
month 2 collections, but after traveling, three different strains appeared at month 3. After 
the intestinal disruption in month 4, two new strains appeared and persisted through 
months 5 and 6 (Fig. 7A). Subject B reported consuming antibiotics several weeks prior 
to the first collection date and experienced gastroenteritis that delayed collection from 
month 4. However no obvious impacts to stability were apparent as half of the strains 
detected in month 3 were also detected in month 4. Subject C recorded no major health 
changes but did note that collections during months 4-6 occurred immediately following 
menstruation. This coincided with an increase in the number of strains detected during 
those three months (Fig. 7C). 
 
Figure 8. Frequency of Strain Detection. Frequency with which strains were detected for each subject. 
Data are represented as percentages of the total number of strains detected over six months from F swab 
samples and the frequency with which a certain percentage of strains were detected.  Detecting a strain 
more than once does not necessarily imply consecutive detection.  For example, strain 34 isolated from 
subject C was detected in month 1 and only again in month 5. 
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E. coli Abundance and Strain Distribution among Subjects 
The number of strains isolated and characterized was a small fraction of the total 
E. coli present in each subject. Fecal samples taken at months 1 and 6 produced counts of 
E. coli around 10
7
- 10
8
 CFU•g
-1
 feces from all 3 subjects. These concentrations are 
consistent with other studies (2, 39). Therefore, the largest samplings (100 isolates at 
months 1 and 6) represent only 0.001% of the total E. coli in 1 gram of feces.  Over the 
course of the six-month study, a total of 962 E. coli isolates were collected, confirmed, 
pyroprinted and found to comprise 153 different strains. Subject A hosted the fewest 
strains, followed in increasing order by subjects B and C (Table 3). The majority of 
strains were unique to 1 subject while 14 (9.2%) were shared by at least 2 subjects and 
only 4 strains (2.6%) were shared by all 3 subjects. Subjects A and C shared the most 
strains (Tables 3 and 4). The most dominant strain (that is, the strain comprised of the 
most E. coli isolates among the isolates sampled) also was shared by all 3 subjects (strain 
9, Table 4). No other correlation between strain dominance and sharing was apparent in 
the data. 
 
Table 3. Quantity of Detected Strains from All Collected E. coli per Subject 
Subject Total no. of strains No. of unique strains* Percentage shared strains** 
A 50 38 24.0 
B 56 49 12.5 
C 66 53 19.7 
*Unique strains are defined in this case as strains detected from only one subject or, not shared by subjects 
**Percentage includes strains shared by one or two other subjects divided by the total number of strains 
detected from that subject. 
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Table 4. Shared Strains between Subjects  
Number of E. coli strains shared between subjects and number of contributing isolates* from each subject. 
 
Shared Strains 
Number of Isolates by Subject Total 
Isolates A B C 
Two 
Subjects 
Strain 11 2 - 7 9 
Strain 12 18 - 8 26 
Strain 29 4 - 3 7 
Strain 30 3 - 2 5 
Strain 31 1 - 5 6 
Strain 97 1 - 1 2 
Strain 110 1 - 2 3 
Strain 27 2 1 0 3 
Strain 54 - 2 1 3 
Strain 88 - 1 3 4 
Three 
Subjects 
Strain 9 51 4 27 82 
Strain 10 5 2 11 18 
Strain 22 21 1 2 24 
Strain 39 1 1 1 3 
Total 14 Strains 110 12 73 195 
*The number of contributing isolates represents the total number of isolates from the indicated subject 
contributing to all strains shared by subjects indicated in column 
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CHAPTER 4 
Discussion 
 
Pyroprinting as a Strain Typing Method 
A bacterial strain is defined based on the typing method used to differentiate 
isolates beyond the species level (12). For example, E. coli strains were originally defined 
as isolates with the same surface antigens identified through serological typing (27, 40). 
However, worldwide collections of enterotoxigenic E. coli are differentiated by only a 
few serotypes. As newer, more discriminating typing methods were introduced, the E. 
coli strains they defined were better differentiated. As a result, literature estimates of 
strain diversity within a host have generally increased over time (12). The current gold 
standard for strain-level analysis of E. coli is multi-locus sequence typing (MLST) where 
gene sequences from 7 different housekeeping genes are compared together (41). MLST 
can differentiate between strains derived from the same parent clone over very short 
evolutionary periods (41). However, this method is neither rapid nor cheap, making the 
analysis of large numbers of isolates difficult. This is the first large-scale use of a new 
method for typing E. coli strains in human hosts and a comparison to existing literature 
values for strain diversity and richness serves to calibrate pyroprinting in relation to other 
methods. 
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E. coli strain diversity and richness among this study’s subjects parallel results 
from previous studies using single enzyme ribotyping, ARA, and AFLP strain typing 
methods. Anderson et al. (25) generated average strain accumulation curves from five 
human subjects using both ribotyping and ARA to analyze 45 and 15 collected isolates, 
respectively. Anderson et al. detected approximately 3 different ARA-defined strains 
using 45 isolates and approximately 2 different ribotype-defined strains using 15 isolates. 
Rarefaction curves generated in our study indicate pyroprinting can discriminate more 
strains in both small 15 isolate sampling efforts (3-8 strains) and large 100 isolates 
sampling efforts (15-32 strains). Over 7 months, Anderson et al. identified between 3 and 
11 strains per subject with ribotyping (analyzing 35 total isolates per subject) and 
between 21 and 33 strains per subject with ARA (analyzing 175 total isolates per 
subject). Over 6 months, Damborg et al. (30) identified between 1 and 10 strains per 
subject using AFLP, although only 10 isolates were collected from each subject over the 
entire length of the study. Over 6 months, our study identified between 15 and 29 strains 
per subject using pyroprinting to analyze 90 isolates per subject. The results between 
similar sampling efforts and temporal analyses from this study and the others mentioned 
provide evidence that pyroprinting may be more discriminating than single enzyme 
ribotyping and ARA. The sampling effort in Damborg et al. is not sufficient to compare 
pyroprinting to AFLP. 
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Effect of Sampling Effort 
One hundred isolates were sampled twice from all three subjects with the 
assumption that this sampling effort would accurately represent the E. coli strains present 
at the time of sampling. Other studies using genotypic methods suggest sampling 15 
isolates would represent a majority of strain diversity actually present in the host (25, 26). 
Lautenbach et al. (26) suggested strains comprising only 5% of the population are likely 
to be sampled 50% of the time if 15 isolates are collected and analyzed using PFGE. 
However, we observed significant differences in the distribution of strains, as well as 
differences in strain representation, between the 100 isolate dilution samples and the 15 
isolate fecal swabs. In some cases, strains detected using 15 isolates were not detected 
when 100 isolates were collected (Fig. 2). These results indicate a large and diverse 
collection of E. coli strains is present in human hosts. We sampled at most 0.001% of the 
total E. coli population present in one gram of feces. A human may host many E. coli 
strains (high strain richness) in relatively equal proportions (high evenness).  Under these 
circumstances many strains will have equal probability for detection, requiring a 
relatively large sample size to accurately represent the diversity within a population of E. 
coli strains. Alternatively, low strain richness and/or evenness would allow a smaller 
sample size to accurately represent strain diversity within the host.  If richness is high but 
evenness is very low in the population, a small sample size will likely represent the most 
abundant strains but will miss detection of the more rare strains. 
This interplay between richness, evenness, and diversity can be observed in the 
strain distribution graphs (Fig. 2) and rarefaction curves (Fig. 3). No significant 
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differences were found between the distributions of strains in three cases (Fig. 2 AM1, 
AM6, BM6); yet in these cases the rarefaction curves for the two levels of sampling 
effort deviate in curvature (Fig. 3A, B, D). This is consistent with an E. coli strain 
population of high richness and low evenness where the most abundant strains are easily 
detected in both sampling efforts (Fig. 2). In addition, this high richness, low evenness 
scenario implies a large number of rare strains are more likely detected with a large 
sampling effort while being missed with a small sampling effort. Thus, the small sample 
size displays greater curvature than the large sample size curve (Fig. 3A, B, D). 
Conversely, a high richness, high evenness scenario will result in different distributions 
(Fig. 2 BM1, CM1, CM6) yet similar rarefaction curves when comparing small and large 
sampling efforts because all major strains are equally likely to be detected. In 
concordance, both rarefaction curves display similar curvature and indicate a much larger 
sample size would be necessary to accurately determine strain richness (Fig. 3C, E, F). 
Very few studies collect 100 or more E. coli isolates from a single human subject, 
yet many still draw conclusions regarding the diversity of E. coli strains within a given 
human host. The Anderson et al. (25) accumulation curves displayed high curvature 
suggesting that the sample sizes selected for ARA and ribotyping in that study adequately 
represented actual strain richness. However, rarefaction curves from subject A in our 
study displayed similar curvature for smaller 15 isolate samples sizes as the ARA (45 
isolates) and ribotype (15 isolates) curves yet lower curvature using larger 100 isolate 
samples. Thus, subjects in the Anderson et al. investigation may have hosted strains with 
low evenness such that rare strains were not detected using only 15 isolates collected for 
ribotyping and increased strain diversity might have been observed with a larger 
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sampling effort. Additionally, the high curvature appearinging with a greater number of 
isolates collected for ARA also suggests the subjects hosted strains with low evenness. It 
is also possible that ARA ultimately is not a very discriminating strain differentiation 
method. Unfortunately, since E. coli strain diversity can vary between human subjects, 
the sample size necessary to accurately detect and represent E. coli strains may depend on 
the individual subject. Thus, larger sample sizes of collected E. coli isolates from 
multiple hosts are necessary to accurately estimate richness and diversity. This poses a 
dilemma for the design and scope of diversity investigations and will likely impact 
estimates of sharing and persistence among hosts as well as comparisons of sampling 
methods. 
 
Effects of Sampling Method 
The four sampling methods tested in this study yielded significantly different 
proportions of some E. coli strains from the same subject when 15 strains were analyzed 
from each sample (Fig. 5). This could be a result of inherent biases in the sampling 
methods. For example, anal swabs might over-sample E. coli strains colonizing locations 
near the sampling site while strains collected from the feces could be colonizing sites 
along the entire length of the colon. The timing of anal swab sampling with respect to 
defecation might also affect strain representation in a sample since fecal material may 
deposit new strains near the sampling site, which could later die off. However, since fecal 
samples were homogenized before swabbing or dilution, position within a fecal discharge 
should not have affected strain representation in these samples. 
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Alternatively, a highly rich and evenly distributed assemblage of strains could 
produce the observed results by random chance due to insufficient sampling effort. For 
example, more richness and high evenness was measured from subject C, and almost no 
strains were detected by more than one sampling method (Fig. 5C) possibly due to a 
similar detection probability of the many strains present in this host. In contrast, the least 
diverse and least even E. coli population was measured from subject A. This may explain 
why, even though only 15 isolates were collected using each sampling method, subject A 
was the only host from which a strain was detected using all four methods (Fig. 5A). 
Because sampling effort may have confounded the methods investigation, no clear 
evidence exists for differences between sampling methods and no conclusions can be 
made. 
Sampling method did not significantly impact diversity or evenness measured 
across the subjects. However, average diversity and evenness values contained large 
variability except in the evenness of strains from swabs taken before defecation.  
Additionally, only three subjects participated in this study. Because of the small sample 
size and large variability that may have masked true differences, we cannot conclude that 
sampling method had no effect on detected strain diversity or evenness. 
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Sharing of E. coli Strains between Hosts 
Little strain sharing was observed between the subjects in this study even though 
strain diversity was high within individuals. However, the host sample size in this study 
was small and may not represent the actual amount of strain sharing in a human 
population. Future studies should be conducted using pyroprinting to collect E. coli from 
larger human populations. If humans do not share many E. coli strains with each other 
this would suggest that either E. coli are not ideal candidates for microbial source 
tracking or very large databases are needed for library-dependent MST to track human 
contributions to E. coli strains present in the environment. 
 
Strain Diversity and Stability 
Although differences in diversity were apparent in the subjects over the course of 
the study, they were not statistically significant based on the diversity indices used to 
characterize the E. coli strain assemblages. Again, average diversity and evenness values 
contained large variability, possibly due to sampling effort or variation in strain stability 
between sampling events, that may have masked true differences in diversity. 
Though it is difficult to relate the specific results of this study to concrete 
conclusions regarding subject health and temporal strain stability, the results seem to 
compliment other studies regarding the stability of the intestinal microflora from 
unhealthy patients since the subject reporting more intestinal unrest also exhibited the 
least temporal stability of E. coli strains. Additional use of pyroprinting may continue to 
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lend new and supportive evidence for using E. coli as an indicator for general intestinal 
health. E. coli of the B2 phylogroup are more frequently associated with intestinal 
disorders such as CD and IBD (14–17). Since the observations of this study correlate host 
environment, travel, and menstruation with changes in both strain diversity and temporal 
stability, observed microflora diversity should be considered along with other host 
variables before making generalized conclusions regarding human health. 
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